Merrimack Pharmaceuticals (MACK) Stock: Tumbles On Trial Failure

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is having an incredibly rough start to the trading session in the pre-market hours this morning, and for good reason. The company was forced to terminate a drug trial due to futility. So, it comes as no surprise that upset investors are sending the stock tumbling. Today, we’ll talk about: … Read more

Merrimack Pharmaceuticals (MACK) Stock: Look Out Below!

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company announced that it is scrapping the development of a treatment due to poor clinical trial results. Of course, the news upset investors who are sending the stock spiraling down. Today, we’ll talk … Read more

Merrimack Pharmaceuticals (MACK) Stock: Gaining On Takeover Rumors

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals was having a relatively interesting start to the trading session today. When the session started, the stock was slightly in the red. From there, it made a quick push to the green before falling back down. Nonetheless,┬áthat all changed minutes ago, as the stock started to spike upward. … Read more

Merrimack Pharmaceuticals (MACK) Stock: Here’s Why It’s Climbing

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals is having an incredibly strong day in the market today, and it seems like the stock’s only going to go further into the green. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching for with regard to MACK ahead. What We’re … Read more

Merrimack Pharmaceuticals (MACK) Stock: Workforce Cuts And CEO Resignation In Focus

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals is having a rough day in the market today, and for good reason. Amid the backdrop of a struggling company, they have chosen to cut a large portion of their workforce. On top of that, it was announced today that the current CEO of the company has made … Read more

Merrimack Pharmaceuticals (MACK) Stock: Collapsing On Earnings

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals is having an incredibly rough day in the market today, and for good reason. The company released its earnings report for the second quarter. Unfortunately, the report was negative. Today, we’ll talk about what we saw from the earnings report, how the stock reacted to the news, and … Read more